About
Since our inception, we’ve been a different type of venture capital investor. We often focus on backing companies in regions of North America bypassed by most other investors. We manage right-sized funds where the financial interests of our fund investors are tightly aligned with our own. And we differentiate ourselves from entrepreneurs as an investor-of-choice by helping them leverage our multi-decade team stability, global industry relationships and lessons learned from building over 100 companies over our careers.
Source: Lumira Capital
Strategy
Lumira executes a consistent, proven investment strategy as a lead investor and active partner with our portfolio companies. We focus on companies whose products offer transformative (not incremental) improvements to patient health outcomes, and the promise of dramatic reductions in the cost of healthcare delivery. Our Canadian heritage helps us “skate to where the puck is going to be,” investing in the new science and clinical insights that we expect will be driving the next decade of patient care.
Source: Lumira Capital
Industry Focus
Health Care, Biotechnology and Diversified
Year Founded
Unknown
Contact Info
Key Personnel
Peter van der Velden MBA, Managing General Partner
Gerry Brunk MBA, Managing Director
Beni Rovinski,Ph.D, Managing Director